Intervention Protocol

Chemotherapy for metastatic and recurrent cervical cancer

  1. Kate Scatchard1,*,
  2. Maxine Flubacher1,
  3. Paul Cornes2,
  4. Tracie Miles3,
  5. Chris Williams4

Editorial Group: Cochrane Gynaecological Cancer Group

Published Online: 8 OCT 2008

Assessed as up-to-date: 16 JUL 2008

DOI: 10.1002/14651858.CD006469

Database Title

Additional Information

How to Cite

Scatchard K, Flubacher M, Cornes P, Miles T, Williams C. Chemotherapy for metastatic and recurrent cervical cancer (Protocol). Cochrane Database of Systematic Reviews 2007, Issue 2. Art. No.: CD006469. DOI: 10.1002/14651858.CD006469.

Author Information

  1. 1

    University Hospitals Bristol NHS Foundation Trust, Haematology and Oncology Centre, Bristol, UK

  2. 2

    Royal United Hospital NHS Trust, Oncology Department, Bath, UK

  3. 3

    Royal United Hospital NHS Trust, Gynaecological Oncology, Bath, UK

  4. 4

    Royal United Hospital, Cochrane Gynaecological Cancer Review Group, Bath, UK

*Kate Scatchard, Haematology and Oncology Centre, University Hospitals Bristol NHS Foundation Trust, Bristol Haematology and Oncology Centre, Horfield Road, Bristol, BS2 8ED, UK. kscatchard@doctors.org.uk.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 8 OCT 2008

SEARCH

ARTICLE TOOLS

View Full Article (HTML) Full (95K)
 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To establish the effectiveness of single agent and combination chemotherapy in the treatment of patients with metastatic or recurrent cervical cancer with regards to progression free survival, overall survival, adverse effects of treatment and quality of life (QOL).

View Full Article (HTML) Full (95K)